Mako Functionally Aligned Total Knee Arthroplasty vs Mako Mechanically Aligned Total Knee Arthroplasty

Sponsor
University College, London (Other)
Overall Status
Recruiting
CT.gov ID
NCT04092153
Collaborator
Stryker European Operations BV (Industry)
100
1
2
48.1
2.1

Study Details

Study Description

Brief Summary

This study evaluates outcomes of robotic-arm assisted mechanically aligned total knee arthroplasty [MA TKA] versus robotic-arm assisted functionally aligned total knee arthroplasty [FA TKA]. Half the study will receive MA TKA and half will receive FA TKA.

Condition or Disease Intervention/Treatment Phase
  • Device: Total knee arthroplasy
N/A

Detailed Description

Total knee arthroplasty [TKA] is an estabilshed treatment for symptomatic end-stage knee osteoarthritis, but there is a higher disatisfaction rate when compared to total hip arthroplasty. The exact aetiology of this is not clear but recent studies have shown one possible reason to be conventional TKA with mechanical alignment [MA] may force the knee into an unnatural position. This may lead to altered knee anatomy and kinematics that may compromise patient satisfaction.

Total knee arthroplasty using functional alignment [FA] aims to restore the patient's prearthritic knee anatomy and native joint kinematics. Early clinical and functional outcome studies have reported promising outcomes in TKA with FA but results of longer term studies have not yet been published.

There are very few prospective studies exploring clinical and radiological outcomes in MA versus FA for TKA. It is possible to improve on previous studies by recording a more comprehensive range of clinical and functional outcome measures, blinding patients and observers recording outcomes of interest, and using longer follow-up times.

Robotic-arm assistance can be used to improve the accuracy of implant positioning. Clinical and functional outcomes should also be correlated to longer-term outcomes to better establish the "safe zone" for functional alignment. The findings of this study will enable an improved understanding of the clinical and functional benefits of FA compared to MA. These outcomes will improve our understanding of the optimal TKA alignment with possible improved outcomes; improved cost-effectiveness by reduced revisions and better patient satisfaction and function; and improved long-term implant survival.

100 patients will be enrolled in a 1:1 ratio between the two treatment groups. Trial patient will be allocated to either the MA TKA ['Control group'] or to the FA TKA ['Investigation group']. Outcomes will be recorded at specific milestones.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Triple (Participant, Care Provider, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
A Prospective Randomised Control Trial Comparing Mako Robotic-arm Assisted Functionally Aligned Total Knee Arthroplasty Versus Mako Robotic-arm Assisted Mechanically Aligned Total Knee Arthroplasty
Actual Study Start Date :
Dec 28, 2018
Anticipated Primary Completion Date :
Dec 31, 2022
Anticipated Study Completion Date :
Dec 31, 2022

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Mechanically aligned

Neutral limb alignment irrespective of the patient's native knee anatomy and joint mechanics

Device: Total knee arthroplasy
Surgical implantation of prosthetic knee using robotic-arm assist

Experimental: Functionally aligned

Restore the patient's own pre-arthritic knee anatomy

Device: Total knee arthroplasy
Surgical implantation of prosthetic knee using robotic-arm assist

Outcome Measures

Primary Outcome Measures

  1. Western Ontario and Mcmaster Universities Arthritis Index (WOMAC) [2 years post-intervention]

    Patient recorded outcome questionnaire evaluating pain, stiffness and disability in affected joint

Secondary Outcome Measures

  1. Lower limb alignment [pre op and 6 weeks post op]

    Assessed using Computerised Tomography (CT) scanogram. Measurements of the hip-knee-angle (HKA), medial proximal tibial angle (MPTA), lateral distal femoral angle (LDFA), femoral flexion angle, and posterior tibial slope will be recorded preoperatively and postoperatively

  2. Operating time [interoperative]

    Operating time [minutes]

  3. Time to discharge [Documented when participant leaves hospital, an average of 72 -96 hours]

    Time to discharge from admission until documented discharge from hospital (hours)

  4. Forgotten Joint Score (FJS) [Pre-op; 6 weeks post-op; 6 months post-op; 1 year post-op; 2 years post-op]

    Patient recorded outcome measure via questionnaire. Score cumulative with -100 being best score and 0 being worst score

  5. Oxford Knee Score (OKS) [Pre-op; 6 weeks post-op; 6 months post-op; 1 year post-op; 2 years post-op]

    Patient recorded outcome measure via questionnaire. 48 is best score and 0 worst score

  6. Short form health survey of 12 items (SF-12), [Pre-op; 6 weeks post-op; 6 months post-op; 1 year post-op; 2 years post-op]

    Patient recorded outcome measure. Questions concerning attitudes to physical and mental heath with 12 questions combined to give overall norm-based values; higher score better, lower score worse.

  7. Knee injury and osteoarthritis outcome score (KOOS) [Pre-op; 6 weeks post-op; 6 months post-op; 1 year post-op; 2 years post-op]

    Patient recorded outcome measure via questionnaire. 6 separate domains including pain, stiffness, quality of life, symptoms, and function; each domain creates percentage with overall cumulative percentage achieved; best score 100%

  8. University of California at Los Angeles knee (UCLA) [Pre-op; 6 weeks post-op; 6 months post-op; 1 year post-op; 2 years post-op]

    Patient recorded outcome measure via questionnaire. Patient records current level of activity; 10 best possible score, 0 worst possible score

  9. European Quality of Life questionnaire with 5 dimensions for adults (EQ-5D) [Pre-op; 6 weeks post-op; 6 months post-op; 1 year post-op; 2 years post-op]

    Patient recorded outcome measure with 5 domains; score -1 to 1, with 1 being best score

  10. Use of mobility aids [during inpatient admission and postoperatively at 6- weeks, 6 months, 1 year and 2 years]

    description of any mobility aids used to assist with ambulation; can describe wheelchair, walker, crutches, sticks or no need for any mobility aid

  11. Mobilisation distance [during inpatient admission and postoperatively at 6- weeks, 6 months, 1 year and 2 years]

    Mobilisation distance (metres)

  12. Range of movement [inpatient admission and postoperatively at 6 weeks, 6 months, 1 year and 2 years]

    Range of movement (degrees) in knee joint

  13. radiosteriometric analysis (RSA) [postoperatively at 2 weeks, 6 weeks, 6 months, 1 year, and 2 years]

    Femoral and tibial implant early migration as assessed using RSA

  14. Gait analysis [performed postoperatively at 6 months and 1 year postoperatively]

    Walking on an instrumented treadmill with force plates

  15. Complications [during inpatient admission and postoperatively at 6- weeks, 6 months, 1 year and 2 years]

    Complications relating to surgery

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years to 80 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Patient has symptomatic knee osteoarthritis requiring primary TKA

  • Patient and surgeon are in agreement that TKA is the most appropriate treatment

  • Patient is fit for surgical intervention following review by surgeon and anaesthetist

  • Patient is between 18-80 years of age at time of surgery

  • Gender: male and female

  • Patient must be capable of giving informed consent and agree to comply with the postoperative review program

  • Patient must be a permanent resident in an area accessible to the study site

  • Patient must have sufficient postoperative mobility to attend follow-up clinics and allow for radiographs to be taken

Exclusion Criteria:
  • Patient is not suitable for routine primary TKA e.g. patient has ligament deficiency that requires a constrained prosthesis

  • Patient has bone loss that requires augmentation

  • Patient is not medically fit for surgical intervention

  • Patient requires revision surgery following previously failed correctional osteotomy or ipsilateral TKA

  • Patient is immobile or has another neurological condition affecting musculoskeletal function

  • Patient is less than 18 years of age or greater than 80 years of age

  • Patient is already enrolled on another concurrent clinical trial

  • Patient is unable or unwilling to sign the informed consent form specific to this study

  • Patient is unable to attend the follow-up programme

  • Patient is non-resident in local area or expected to leave the catchment area postoperatively

Contacts and Locations

Locations

Site City State Country Postal Code
1 University College London Hospital NHS Foundation Trust London United Kingdom NW1 2PG

Sponsors and Collaborators

  • University College, London
  • Stryker European Operations BV

Investigators

  • Study Chair: Fares S Haddad, UCLH

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
University College, London
ClinicalTrials.gov Identifier:
NCT04092153
Other Study ID Numbers:
  • 17/0721
First Posted:
Sep 17, 2019
Last Update Posted:
Nov 30, 2021
Last Verified:
Nov 1, 2021
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
Yes
Product Manufactured in and Exported from the U.S.:
Yes
Keywords provided by University College, London
Additional relevant MeSH terms:

Study Results

No Results Posted as of Nov 30, 2021